Universal Registration Document 2019

22 LISI 2019 UNIVERSAL REGISTRATION DOCUMENT Consolidated financial statements 2 DENTAL IMPLANTS MINIMALLY INVASIVE SURGERY INSTRUMENTS INSTRUMENTS VASCULAR IMPLANTS UPPER EXTREMITIES IMPLANTS MAXILLOFACIAL IMPLANTS TRAUMATOLOGY IMPLANTS TOTAL KNEE PROSTHESIS LOWER EXTREMITIES IMPLANTS SPINAL IMPLANTS TOTAL HIP PROSTHESIS UPPER EXTREMITIES IMPLANTS LISI MEDICAL 146.2 M€ SALES REVENUE 8% of consolidated sales revenue 919 EMPLOYEES 8% of Group headcount 10.6 M€ CAPEX 9% of Group’s total CAPEX Activity Medical implant and auxiliary parts subcontractor Flagship products Orthopedics and osteosynthesis; Hip; Knee; Shoulder; Spine; Trauma; Extremities; OMFS; Orthopedic instruments. Advanced surgical technologies: Cardiovascular; Urology; Manual and robotic laparoscopy. Customers Ace Surgical; Alphatec; Argen; Boston Scientific; Coloplast; Integra Lifescience; Intuitive surgical; Johnson & Johnson subsidiaries; Medacta; Medicrea; Medtronic; Meril; Next Ortho; Osd; Osteocentric Technologies; Smiths; Stryker; Wright Medical; Zimmer-Biomet. Competitors Avalign; CeramTec; Freudenberg Medical; Integer; Marle; NN Inc; Norwood; Orchid; TE Connectivity (Creganna); Tecomet; Viant. LISI MEDICAL is involved in the design, manufacturing and marketing phases of all above-mentioned products. LISI MEDICAL is positioned as a subcontractor. The main raw materials used are the following: titanium, chromium, cobalt, plastic (PEEK, PEHT), etc. The main technologies used are turning, milling, forging, packaging under sterile conditions, laser marking and special processes.